title: Effect of antenatal betamethasone use on adrenal gland size and endogenous cortisol and 17-hydroxyprogesterone in preterm neonates.
abstract: OBJECTIVE
  To assess the effect of antenatal betamethasone use on adrenal gland size and adrenal hormones in preterm neonates who had gestational ages of 27-36 weeks.
  
  
  METHODS
  Sixty-six neonates divided into two groups: betamethasone group, whose mothers received betamethasone 12 mg two times 24 h apart, and no betamethasone group, whose mothers did not receive any steroid agent during the antenatal period. Serum 17-hydroxyprogesterone (17-OHP) levels and cortisol levels were measured during the first six hours of life. In addition, adrenal gland length and width were determined on the first day of life. Hormone tests and ultrasonographic evaluation were repeated on the fifth day of life.
  
  
  RESULTS
  We found statistically significant reductions in 17-OHP and cortisol levels at birth in corticosteroid-exposed neonates (p < 0.05). There was no significant difference between the study groups with regard to adrenal gland length and width (p > 0.05).
  
  
  CONCLUSIONS
  This study demonstrates that betamethasone use in preterm neonates reduces endogenous 17-OHP and cortisol levels; however, it has no effect on adrenal gland size.
authors.affiliation: Department of Neonatology, Cumhuriyet University School of Medicine, Sivas, Turkey. deryabuyukkayhan@hotmail.com
authors.forename: Derya
authors.initials: D
authors.lastname: Buyukkayhan
authors.forename: Mehmet Adnan
authors.initials: MA
authors.lastname: Ozturk
authors.forename: Selim
authors.initials: S
authors.lastname: Kurtoglu
authors.forename: Esad
authors.initials: E
authors.lastname: Koklu
authors.forename: Ali
authors.initials: A
authors.lastname: Yikilmaz
mesh_terms: D019326:17-alpha-Hydroxyprogesterone / Q000097:blood*; D000311:Adrenal Glands / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D000328:Adult; D001623:Betamethasone / Q000008:administration & dosage*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007231:Infant, Newborn; D007234:Infant, Premature / Q000097:blood*; D008297:Male; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000097:blood*; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control
chemical_list: D005938:Glucocorticoids; D019326:17-alpha-Hydroxyprogesterone; D001623:Betamethasone; D006854:Hydrocortisone